Anzu Special Acquisition Corp I expands board to five, appoints Hirsch as CFO and Dewbrey as director

Envoy Medical, Inc.

Board increased from 3 to 5 directors; Hirsch and Dewbrey appointed as directors effective Oct 1, 2022.
Hirsch named CFO and Corporate Secretary; previously COO/CFO of Cascade Acquisition Corp.
Dewbrey determined independent, appointed to Audit, Compensation, Nominating committees and chair of Compensation.
Sponsor transferred 25,000 Class B shares to each new director.
Indemnification agreements entered with Hirsch and Dewbrey.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Daniel J. Hirsch

Chief Financial Officer and Corporate Secretary

COCH · Envoy Medical, Inc.

Effective: 2022-10-01
Filed: October 4, 2022, 7:59 PM ET

the Board appointed Mr. Hirsh as the Chief Financial Officer and Corporate Secretary of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Daniel J. Hirsch was appointed as Chief Financial Officer and Corporate Secretary at Envoy Medical, Inc..

Action: appointed
Role: Chief Financial Officer and Corporate Secretary

Exact text from the filing

the Board appointed Mr. Hirsh as the Chief Financial Officer and Corporate Secretary of the Company.

View on SEC.gov

Envoy Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-22-105831

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.